Denali Therapeutics Inc. is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. DNLI has around 6.4M shares in the U.S. ETF market. The largest ETF holder of DNLI is the iShares Russell 2000 ETF (IWM), with approximately 1.30M shares. Investors may also find of interest that the ETF with the largest allocation to DNLI stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.72%. On average, U.S. ETFs allocate 0.12% of DNLI to their portfolios.
Additionally, DNLI is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DNLI as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.